About this trial
Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Hypoparathyroidism defined by low serum calcium < 2.2 mmol/l (< 88 mg/l) associated with inadequate PTH (low or normal) and normal creatinine
Disqualifiers
Cervical surgery < 6 months.
Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.
Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.
Familial hypocalcemia hypercalciuria.
Trial population
Consecutive patients suffering from hypoparathyroidism and/or pseudo hypoparathyroidism
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of primary hypoparathyroidism
Number of subjects with primary hypoparathyroidism at enrollment
Incidence of congenital hypoparathyroidism
Number of subjects with congenital hypoparathyroidism at enrollment
Incidence of acquired hypoparathyroidism
Number of subjects with acquired hypoparathyroidism at enrollment
Incidence of secondary hypoparathyroidism
Number of subjects with secondary hypoparathyroidism at enrollment
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Dacima Consulting
Lead sponsor
Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques
Collaborator
This trial is not recruiting at the moment. You can still explore other options: